REFERENCE
Greenberg D, Cohen JT, Fang C, Neumann PJ.How Much Does Adjusting For Health-Related Quality Of Life Matter In Cost-Effectiveness Analysis? A Comparison Of Cost/Life Year And Cost/Qaly Estimates For Cancer Interventions. 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: abstr. CN1, 24 Oct 2009. Available from: URL: http://www.ispor.org/Events/Index.aspx?eventId=30
Rights and permissions
About this article
Cite this article
Adjusting for health-related QOL does not appear to substantially affect cost per life year (LY) ratios for most cancer studies. Pharmacoecon. Outcomes News 591, 6 (2009). https://doi.org/10.2165/00151234-200905910-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905910-00009